help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMuth, J. P.
Right arrow Articles by Willey, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMuth, J. P.
Right arrow Articles by Willey, J. C.

Am. J. Respir. Cell Mol. Biol., Volume 19, Number 1, July, 1998 18-24

RAPID COMMUNICATION
The Gene Expression Index c-myc × E2F-1/p21 Is Highly Predictive of Malignant Phenotype in Human Bronchial Epithelial Cells

Jeffrey P. DeMuth, Clara M. Jackson, David A. Weaver, Erin L. Crawford, Dennis S. Durzinsky, Samuel J. Durham, Aiman Zaher, Edwin R. Phillips, Sadik A. Khuder, and James C. Willey

Medical College of Ohio, Departments of Medicine, Pathology and Surgery, Toledo, Ohio

Recent methodological developments allow expression measurement of many genes simultaneously, thereby revealing patterns of gene expression that can be related to phenotype. We hypothesized that through the use of such methods we could identify patterns of gene expression associated with the malignant phenotype in human bronchial epithelial cells (BEC). To test this hypothesis, a recently developed quantitative reverse transcriptase polymerase chain reaction method was used to assess simultaneously expression of 15 genes mechanistically associated with cell-cycle control (c-myc, E2F-1, p21, rb, PCNA, cyclin D2, cyclin D3, cyclin E, cdc2, CDK2, CDK4, mad, max p21, max p22, and p53) in normal cell cultures from five individuals and in nine different malignant BEC lines. Relative to the mean expression levels in cultured normal cell populations, expression of c-myc, E2F-1, PCNA, cyclin E, and CDK4 messenger RNA (mRNA) were significantly increased and expression of p21 and p53 mRNA were significantly decreased in one or two, but not all three subtypes (squamous, adenocarcinoma and small cell) of carcinoma cell lines evaluated. No single cell-cycle control gene discriminated all three subtypes from normal cell populations. In contrast, the gene expression index c-myc × E2F-1/p21 separated all carcinoma cell lines from all normal cell populations initially evaluated. This malignancy index was validated in an additional three cultured normal BEC and three carcinoma cell lines, as well as three pairs of matched primary normal bronchial epithelial and primary bronchogenic carcinoma samples, and three pairs of matched primary normal lung parenchyma and primary bronchogenic carcinoma tissue. Again, the c-myc × E2F-1/ p21 index successfully discriminated all cultured and primary normal from malignant samples and thereby had a predictive value of 1 (no false positives and no false negatives). We hypothesize that because of functional mutations in cell-cycle regulatory genes (e.g., p53 and/or rb), cells lose the ability to maintain a pattern of gene expression mechanistically associated with normal, division-limited homeostatic equilibrium. Because the c-myc × E2F-1/p21 gene expression index has high specificity for malignant tissue, it will allow confirmation that there is a significant amount of tumor tissue present in small (e.g., fine-needle) biopsy specimens prior to evaluating them for expression of other genes, such as those involved in chemoresistance or radioresistance. In addition, the goal of most gene therapy efforts is to alter levels of gene expression quantitatively. This index and others derived in a similar manner may better define potential gene therapy targets as well as response of targeted genes to therapy.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
K. A. Warner, E. L. Crawford, A. Zaher, R. J. Coombs, H. Elsamaloty, S. L. Roshong-Denk, I. Sharief, G. V. Amurao, Y. Yoon, A. Y. Al-Astal, et al.
The c-myc x E2F-1/p21 Interactive Gene Expression Index Augments Cytomorphologic Diagnosis of Lung Cancer in Fine-Needle Aspirate Specimens
J. Mol. Diagn., August 1, 2003; 5(3): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Tsukuda, R. Wiewrodt, K. Molnar-Kimber, V. P. Jovanovic, and K. M. Amin
An E2F-responsive Replication-selective Adenovirus Targeted to the Defective Cell Cycle in Cancer Cells: Potent Antitumoral Efficacy but No Toxicity to Normal Cell
Cancer Res., June 1, 2002; 62(12): 3438 - 3447.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Banerjee, R. Gorlick, A. Liefshitz, K. Danenberg, P. C. Danenberg, P. V. Danenberg, D. Klimstra, S. Jhanwar, C. Cordon-Cardo, Y. Fong, et al.
Levels of E2F-1 Expression Are Higher in Lung Metastasis of Colon Cancer As Compared with Hepatic Metastasis and Correlate with Levels of Thymidylate Synthase
Cancer Res., May 1, 2000; 60(9): 2365 - 2367.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
E. L. Crawford, S. A. Khuder, S. J. Durham, M. Frampton, M. Utell, W. G. Thilly, D. A. Weaver, W. J. Ferencak, C. A. Jennings, J. R. Hammersley, et al.
Normal Bronchial Epithelial Cell Expression of Glutathione Transferase P1, Glutathione Transferase M3, and Glutathione Peroxidase Is Low in Subjects with Bronchogenic Carcinoma
Cancer Res., March 1, 2000; 60(6): 1609 - 1618.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. N. Rom
Assessment of Activation, Differentiation, and Carcinogenesis of Lung Cells by Quantitative Competitive RT-PCR
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 3 - 5.
[Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. C. Willey, E. L. Crawford, C. M. Jackson, D. A. Weaver, J. C. Hoban, S. A. Khuder, and J. P. DeMuth
Expression Measurement of Many Genes Simultaneously by Quantitative RT-PCR Using Standardized Mixtures of Competitive Templates
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 6 - 17.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1998 American Thoracic Society.